Pfizer Sells German Generics Unit | Business| Economy and finance news from a German perspective | DW | 27.06.2005
  1. Inhalt
  2. Navigation
  3. Weitere Inhalte
  4. Metanavigation
  5. Suche
  6. Choose from 30 Languages


Pfizer Sells German Generics Unit

US pharmaceuticals giant Pfizer said Monday it had sold its German generic drugs unit Heumann Pharma to Torrent Pharma GmbH, a subsidiary of the Indian energy and

pharmaceuticals conglomerate Torrent. Financial details were not disclosed, but Heumann Pharma, which is based in Nuremberg, has annual sales of 50 million euros ($60.5

million) and employs a workforce of 164, Pfizer Deutschland said in a statement. Heumann's drug manufacturing plant Heumann PCS in Feucht, outside Nuremberg, which employs a workforce of 430, was not included in the deal, Pfizer noted. The US giant said that generic drugs no longer belonged to Pfizer's core business of developing new, innovative drugs.

DW recommends